PT443 – Swimming in the Sacred: The Wisdom of Underground Female...

Psychedelic Bulletin #145: MAPS’ Second Phase 3 Study Published; EMA’s New...

Numinus Congratulates MAPS on its Phase 3 Study Results Published in...

Numinus Takes Actions to Accelerate its Path to Profitability by Focusing...

COMPASS Pathways appoints Daphne Karydas to its Board of Directors

Clearmind Medicine Closes US$2.25 Million Public Offering

Reunion Neuroscience Inc. Announces FDA Clearance of IND Application to Initiate...

PT442 – Burning Questions About Burning Man: Mud, Ebola, and the...

Optimi Health Celebrates Encouraging Results from the MAPS Phase 3 MDMA-Assisted...

Clearmind Medicine Announces Pricing of US$2.25 Million Public Offering

Load more